11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET).

Autor: Lakomý, Radek1,2 (AUTHOR), Lojová, Martina3 (AUTHOR), Souckova, Lenka4,5 (AUTHOR), Hynkova, Ludmila6,7 (AUTHOR), Polachova, Katerina6,7 (AUTHOR), Vasina, Jiri8 (AUTHOR), Demlová, Regina3,4 (AUTHOR), Poprach, Alexandr1,2 (AUTHOR), Sana, Jiri1,2 (AUTHOR), Prochazka, Tomas6,7 (AUTHOR), Smrcka, Martin9,10 (AUTHOR), Fadrus, Pavel9,10 (AUTHOR), Jancalek, Radim9,11 (AUTHOR), Selingerova, Iveta4,12 (AUTHOR), Belanova, Renata13 (AUTHOR), Slampa, Pavel6,7 (AUTHOR), Pospisil, Petr6,7 (AUTHOR), Kazda, Tomas6,7,12 (AUTHOR) tomas.kazda@mou.cz
Zdroj: BMC Cancer. 6/15/2024, Vol. 24 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje